Gilead Sciences Inc.

NAS: GILD

GO
/marketstate/country/us

Before the Bell

/zigman2/quotes/210293917/composite

$

61.69

Change

0.00 0.00%

Volume

Volume 734

Oct 3, 2022, 8:03 a.m.

Real time quotes

/zigman2/quotes/210293917/composite

Previous close

$ 61.69

$ 61.69

Change

-1.38 -2.19%

Day low

Day high

$61.61

$63.58

Open
Open: 63.16

52 week low

52 week high

$57.17

$74.12

Open

Market cap

$77.32B

Average volume

7.17M

P/E ratio

18.81

Rev. per Employee

$1.91M

EPS

3.28

Dividend

0.73

Div yield

4.73%

Ex dividend date

9/14/22

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/gild

MarketWatch News on GILD

  1. Gilead Sciences Inc. stock underperforms Friday when compared to competitors

    4:55 p.m. Sept. 30, 2022

    - MarketWatch Automation

  2. Gilead Sciences Inc. stock underperforms Thursday when compared to competitors

    4:55 p.m. Sept. 29, 2022

    - MarketWatch Automation

  3. Gilead Sciences Inc. stock outperforms market on strong trading day

    4:55 p.m. Sept. 28, 2022

    - MarketWatch Automation

  4. Gilead Sciences Inc. stock rises Tuesday, outperforms market

    4:55 p.m. Sept. 27, 2022

    - MarketWatch Automation

  5. Gilead Sciences Inc. stock underperforms Monday when compared to competitors

    4:55 p.m. Sept. 26, 2022

    - MarketWatch Automation

  6. Gilead Sciences Inc. stock outperforms market despite losses on the day

    4:55 p.m. Sept. 23, 2022

    - MarketWatch Automation

  7. Gilead Sciences Inc. stock rises Thursday, outperforms market

    4:55 p.m. Sept. 22, 2022

    - MarketWatch Automation

  8. Gilead Sciences Inc. stock falls Wednesday, still outperforms market

    4:55 p.m. Sept. 21, 2022

    - MarketWatch Automation

  9. Gilead Sciences Inc. stock falls Tuesday, underperforms market

    4:56 p.m. Sept. 20, 2022

    - MarketWatch Automation

  10. Gilead Sciences Inc. stock rises Monday, still underperforms market

    4:55 p.m. Sept. 19, 2022

    - MarketWatch Automation

  11. Gilead Sciences Inc. stock rises Friday, outperforms market

    4:55 p.m. Sept. 16, 2022

    - MarketWatch Automation

  12. EU regulator recommends extending Gilead's COVID treatment Veklury for use in pediatric patients

    6:49 a.m. Sept. 16, 2022

    - Ciara Linnane

  13. Gilead COVID-19 drug gets expanded WHO recommendation

    6:48 p.m. Sept. 15, 2022

    - Wallace Witkowski

  14. Gilead Sciences Inc. stock outperforms market despite losses on the day

    4:55 p.m. Sept. 15, 2022

    - MarketWatch Automation

  15. Gilead Sciences Inc. stock falls Tuesday, still outperforms market

    4:55 p.m. Sept. 13, 2022

    - MarketWatch Automation

  16. Gilead Sciences Inc. stock outperforms competitors on strong trading day

    4:55 p.m. Sept. 12, 2022

    - MarketWatch Automation

  17. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/gild

Other News on GILD

  1. Gilead Sciences: Becoming A Cure

    16 min ago

    - Seeking Alpha

  2. Is Invesco Dynamic Pharmaceuticals ETF (PJP) a Strong ETF Right Now?

    6:20 a.m. Today

    - Zacks.com

  3. I-Mab: Another CD47 Inhibitor Biotech With Great Potential

    2:30 p.m. Sept. 27, 2022

    - Seeking Alpha

  4. Top Research Reports for Union Pacific, AT&T & Blackstone

    1:51 p.m. Sept. 23, 2022

    - Zacks.com

  5. Cryoport: A Rare Investing Opportunity

    7:11 p.m. Sept. 22, 2022

    - Seeking Alpha

  6. NuCana: An Intriguing 'Sum Of The Parts' Story

    3:40 p.m. Sept. 22, 2022

    - Seeking Alpha

  7. A Dive Into Gilead Sciences' New HIV Medication

    10:34 a.m. Sept. 22, 2022

    - Seeking Alpha

  8. A Chronic Disease Still Waiting for a Drug

    9:03 a.m. Sept. 20, 2022

    - David Wainer

  9. "The Era of the Gene-Edited Human Is Here"

    5:35 p.m. Sept. 19, 2022

    - Motley Fool

  10. Should You Invest in the VanEck Biotech ETF (BBH)?

    6:20 a.m. Sept. 19, 2022

    - Zacks.com

  11. WHO Recommends Gilead's (GILD) Veklury for Severe COVID-19

    2:58 p.m. Sept. 16, 2022

    - Zacks.com

  12. Loading more headlines...
/news/pressrelease/company/us/gild

Press Releases on GILD

  1. Gilead Sciences GILD Pivots Trading Plans and Risk Controls

    6:31 a.m. Oct. 1, 2022

    - Stock Traders Daily

  2. Learn to Evaluate Gilead Sciences (GILD) using the Charts

    11:17 a.m. Sept. 21, 2022

    - Stock Traders Daily

  3. Gilead Sciences Completes Acquisition of MiroBio

    4:30 p.m. Sept. 20, 2022

    - BusinessWire - BZX

  4. Gilead Sciences GILD Proactive Strategies

    6:41 p.m. Sept. 11, 2022

    - Stock Traders Daily

  5. Gilead Sciences (GILD) Trading Report

    2:42 a.m. Sept. 2, 2022

    - Stock Traders Daily

  6. Diverticulitis Drugs Market Trends, Share & Size Report 2029

    4:22 a.m. Aug. 30, 2022

    - AmericaNewsHour

  7. Loading more headlines...

Rates »

Link to MarketWatch's Slice.